AIM ImmunoTech

AIM ImmunoTech is a biopharmaceutical company based in North Brunswick, NJ, dedicated to developing innovative immunotherapy solutions for a wide range of debilitating and life-threatening conditions. Their lead program, Ampligen, is an immuno-modulator that has demonstrated broad spectrum activity in preclinical studies and is currently being evaluated in clinical trials for various diseases, including oncology, immune disorders, and viral diseases. With a focus on improving patients' lives, AIM ImmunoTech aims to develop therapeutic solutions that have the potential to address unmet medical needs and provide better treatment options. Through their research and development efforts, they strive to advance the field of immunology and contribute to a better future for patients worldwide.Generated from the website

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers throughout the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, as well as ophthalmic surgical and pharmaceutical products. Founded in 1853, the company is headquartered in Rochester, N.Y. Bausch & Lomb s 2004 revenues were $2.2 billion, and it employs approximately 12,400 people worldwide. The company s products are available in more than 100 countries. Bausch & Lomb s Vision Care business manufactures and markets some of the world s most comprehensive lines of eye care products.

Ortho-McNeil-Janssen Pharmaceuticals offers a range of health care products for the treatment of several infectious diseases, as well as pain management. The company s sister concern Ortho-McNeil, which serves primary care hospitals and other care facilities. Ortho-McNeil s products are available under the DURAGESIC, LEVAQUIN, FLOXIN, NIZORAL and PROPULSID brads. The company provides injections, shampoos, caplets, tablets and capsules. Ortho-McNeil offers the ACIPHEX product, which is used of the treatment of heartburn and other symptoms associated with acid reflux disease. The company additionally provides the DORIBAX product for patients with gram negative infections. Ortho-McNeil undertakes several research and development activities.